BioSpace News Archive

Purdue Pharma L.P. (“Purdue”) announced that FDA has accepted and granted priority review to the company’s Abbreviated New Drug Application for the vial dosage form of nalmefene hydrochloride injection.

Omeros Corporation today announced publication of the article “Selective inhibition of phosphodiesterase 7 enzymes reduces motivation for nicotine use through modulation of mesolimbic dopaminergic transmission” in the peer-reviewed Journal of Neuroscience.

CohBar, Inc. today announced its Chief Executive Officer Dr. Joseph Sarret will present a corporate overview at the BIO 2021 Digital Conference, to be held on June 14 - 18, 2021.

ScienceMedia has tackled one of the biggest challenges facing decentralized trials – high staff turnover rates.

OliPass Corporation, a South Korea based biotech specialized in the development of RNA therapeutics, announced that it is expanding its Scientific Advisory Board (“SAB”) for SCN9A antisense pain killer OLP-1002 to include Professor Patrick M. Dougherty of The University of Texas MD Anderson Cancer Center and Professor Robert H. Dworkin of University of Rochester Medical Center.

Phosplatin Therapeutics Inc. announced today that it has been selected to deliver a presentation on the development program of its lead candidate, PT-112, an immunogenic cell death (ICD) inducer, at 2021 BIO Digital, the premier biotech event.

Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of a broad spectrum of diseases, announced today that the company will participate in 1x1 meetings with investors and potential partners at BIO Digital 2021 being held June 10-11 and June 14-18, 2021.

As part of the Biden Administration’s National Month of Action, Walgreens will extend pharmacy hours of operation each Friday in June to provide those who may have limited time the additional flexibility needed to get a COVID-19 vaccine.

Ossianix, an antibody engineering company, and the University of Graz announced the publication of a preclinical study that describes discovery of highly potent neutralizing single domain shark antibodies directed against the SARS-CoV-2 spike protein.

Matrix Clinical Solutions, a Matrix Medical Network® (Matrix) business, today announced the appointment of Dawn Carter as President of the Employee Health business unit